Recombinant Human CEACAM7 (C-6His)

Description

EnkiLife provides the Recombinant Human CEACAM7 (C-6His) protein,aslo know as Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7,Carcinoembryonic Antigen CGM2,CEACAM7,CGM2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7 is produced by our Mammalian expression system and the target gene encoding Thr36-Phe142 is expressed with a 6His tag at the C-terminus.Accession:AAI21133.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:13.1 KDa. Background:Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7 (CEACAM7) is a member of the immunoglobulin superfamily A and CEA family. CEACAM7 localizes to the cell membrane and contains one Ig-like C2-type domain and one Ig-like V-type domain. The expression of CEACAM7 is significantly decreased in rectal cancer. Differences in CEACAM7 expression levels between long-term survivors and those with recurrent disease introduce a potential tumor marker to define a subset of patients who benefit most from adjuvant therapy.